Recent Research
Research
High Drug Prices, Big R&D Spenders and “Free Riders”: Canada in the Topsy Turvy World of Pharmaceuticals
February 26, 2019
Research
This area covers the impact of policies affecting Canadians’ health and long-term care choices and outcomes, for example regarding access to and quality of care, funding arrangements and incentives, pharmaceuticals policies, intergenerational equity considerations, and the impact of these choices on the public purse.